A detailed history of Mjp Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Mjp Associates Inc holds 2,876 shares of AMGN stock, worth $956,126. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,876
Previous 2,915 1.34%
Holding current value
$956,126
Previous $828,000 8.45%
% of portfolio
0.19%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$262.75 - $319.31 $10,247 - $12,453
-39 Reduced 1.34%
2,876 $898,000
Q1 2024

Apr 11, 2024

BUY
$268.87 - $324.56 $338,776 - $408,945
1,260 Added 76.13%
2,915 $828,000
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $128,617 - $145,095
-503 Reduced 23.31%
1,655 $476,000
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $111,730 - $138,716
511 Added 31.03%
2,158 $579,000
Q2 2023

Jul 11, 2023

SELL
$214.27 - $253.37 $6,428 - $7,601
-30 Reduced 1.79%
1,647 $365,000
Q1 2023

Apr 17, 2023

BUY
$225.79 - $275.2 $21,450 - $26,144
95 Added 6.01%
1,677 $405,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $17,635 - $22,407
77 Added 5.12%
1,582 $0
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $2,244 - $2,531
-10 Reduced 0.66%
1,505 $339,000
Q2 2022

Jul 11, 2022

SELL
$230.71 - $256.74 $2,076 - $2,310
-9 Reduced 0.59%
1,515 $369,000
Q1 2022

Apr 19, 2022

SELL
$219.27 - $242.57 $55,036 - $60,885
-251 Reduced 14.14%
1,524 $369,000
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $69,210 - $79,204
-348 Reduced 16.39%
1,775 $402,000
Q3 2021

Oct 13, 2021

SELL
$212.27 - $248.7 $424 - $497
-2 Reduced 0.09%
2,123 $451,000
Q2 2021

Jul 14, 2021

BUY
$233.58 - $259.14 $1,635 - $1,813
7 Added 0.33%
2,125 $518,000
Q1 2021

May 04, 2021

SELL
$221.91 - $258.6 $3,328 - $3,879
-15 Reduced 0.7%
2,118 $527,000
Q4 2020

Jan 27, 2021

BUY
$216.38 - $257.67 $461,538 - $549,610
2,133 New
2,133 $490,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mjp Associates Inc Portfolio

Follow Mjp Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mjp Associates Inc with notifications on news.